XML 70 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 30, 2012
Equity-Based Compensation [Abstract]  
Schedule Of Assumptions Used To Calculate Weighted Average Fair Value Of Stock Option Grants

 

 

3/30/12

 

 

4/1/11

 

Expected volatility

 

 

43.3

 

 

46.8

Risk-free interest rate

 

 

0.9

 

 

2.2

Expected term (in years)

 

 

5.3

 

 

 

5.3

 

Expected dividend yield

 

 

2.0

 

 

1.5

Schedule Of Stock Option Activity

 

 

Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic
Value

(in  millions)

 

Outstanding – beginning of year

 

 

20,719,482

 

 

$

7.68

 

 

 

Granted

 

 

1,801,219

 

 

$

3.99

 

 

 

Exercised

 

 

(49,195

 

$

0.40

 

 

 

Forfeited/expired

 

 

(513,060

 

$

7.85

 

 

 

 

 

 

 

 

 

 

Outstanding – end of period

 

 

21,958,446

 

 

$

7.39

 

 

 

4.2

 

 

$

0.6

 

 

 

 

 

 

 

 

Exercisable – end of period

 

 

17,483,104

 

 

$

7.93

 

 

 

3.0

 

 

$

0.5

 

Shares vested or expected to vest

 

 

21,559,758

 

 

$

7.44

 

 

 

4.1

 

 

$

0.6

 

Schedule Of Cash-Settled Stock Appreciation Rights Activity

 

 

Shares

 

 

Weighted
Average
Exercise
Price

 

Outstanding – beginning of year

 

 

492,131

 

 

$

6.81

 

Granted

 

 

16,200

 

 

$

3.98

 

Forfeited/expired

 

 

(15,736

 

$

7.58

 

 

 

 

 

 

Outstanding – end of period

 

 

492,595

 

 

$

6.69

 

 

 

 

 

 

Schedule Of Restricted Stock Unit Activity

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Non-vested – beginning of year

 

 

4,854,587

 

 

 

$6.29

 

Granted

 

 

1,959,811

 

 

 

$3.99

 

Vested

 

 

(803,100

 

 

$5.38

 

Forfeited

 

 

(392,670

 

 

$5.96

 

 

 

 

 

 

Non-vested – end of period

 

 

5,618,628

 

 

 

$5.64

 

 

 

 

 

 

Schedule Of Performance Stock Unit Activity

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Non-vested – beginning of year

 

 

2,269,410

 

 

 

$5.51

 

Granted

 

 

1,887,064

 

 

 

$3.99

 

Vested

 

 

(734,185

 

 

$5.15

 

Forfeited

 

 

(1,134,913

 

 

$5.37

 

 

 

 

 

 

Non-vested – end of period

 

 

2,287,376

 

 

 

$4.44

 

 

 

 

 

 

Schedule Of Equity-Based Compensation Expense

 

 

First Quarter

 

 

 

3/30/12

 

 

4/1/11

 

Cost of revenue – products

 

$

0.4

 

 

$

0.5

 

Cost of revenue – services

 

 

0.5

 

 

 

0.6

 

Research and development

 

 

1.8

 

 

 

2.5

 

Sales and marketing

 

 

0.9

 

 

 

1.3

 

General and administrative

 

 

2.0

 

 

 

2.7

 

 

 

 

 

 

 

 

 

Equity-based compensation expense before income taxes

 

 

5.6

 

 

 

7.6

 

Income tax benefit

 

 

(0.1

 

 

(1.4

 

 

 

 

 

 

 

 

Total equity-based compensation expense after income taxes

 

$

5.5

 

 

$

6.2

 

 

 

 

 

 

 

 

 

Schedule Of Total Equity-Based Compensation Expense By Type

 

 

First Quarter

 

 

 

3/30/12

 

 

4/1/11

 

Stock options

 

$

1.1

 

 

$

1.3

 

Cash-Settled SARs

 

 

0.1

 

 

 

(0.1

Restricted Stock

 

 

3.4

 

 

 

4.4

 

Performance stock units

 

 

1.0

 

 

 

2.0

 

 

 

 

 

 

 

 

 

Total

 

$

5.6

 

 

$

7.6